3648 results for «682»

Filter By

3648 results

Antithrombotic strategies in challenging clininal scenarios

21 May 2026 – From EuroPCR 2026

This session presents a comprehensive overview of antithrombotic strategies tailored to challenging clinical scenarios. Topics include management in elderly patients with atrial fibrillation undergoing DES implantation, the use of low-dose Cangrelor and Bivalirudin during PCI under ECMO in cardiac arrest, polymer types in stents, and timing...

Complication two: PCI complications occurring during PCI for NSTEMI

21 May 2026 – From EuroPCR 2026

This session addresses the spectrum of PCI complications encountered during NSTEMI interventions, including coronary perforations, challenges with unexpanded covered stents, IVUS-related issues, giant coronary aneurysms at bifurcations, and distal wire perforations, providing critical lessons in complication management and operator coordination.

New insights in coronary atherosclerosis using intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...

Increasing efficiency in CTO PCI

21 May 2026 – From EuroPCR 2026

Focused on increasing efficiency in CTO PCI, this session covers diverse technical approaches including overcoming unexpected anatomical barriers, multiple wiring techniques, microchannel selection in bifurcation lesions, managing tortuous right coronary artery CTOs, unconventional strategies for uncrossable CTOs, and adapting perspectives in patients with previous CABG.

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

31 Aug 2024

Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Alessandro Sticchi

Author

Alessandro Sticchi
Tri.fr trial

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Ali Nazmi Calik

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial
Didn’t find what you were looking for?